US health officials in talks with 14 companies over drug prices, Kennedy says
- Country:
- United States
The United States is in negotiations with 14 companies over its plan to implement so-called most-favored-nation pricing on pharmaceutical drugs, Health Secretary Robert F. Kennedy Jr. said on Tuesday.
Kennedy made the comments in a Cabinet meeting alongside U.S. President Donald Trump.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Kennedy
- U.S.
- Donald Trump
- The United States
- Robert F. Kennedy Jr.
- Health
- Cabinet
Advertisement
ALSO READ
Market Caution: U.S. Futures Fall Amid Inflation Worries and Tech Slump
Brazil Strikes Back: Reciprocity Law Targets U.S. Tariff Hikes
Norwegian Sovereign Fund's Divestment Sparks U.S. Tensions
Norwegian Sovereign Fund Sparks Diplomatic Tension with U.S.
U.S. Stock Futures Slide Amid Inflation Concerns and Rate Speculation
Google News